Literature DB >> 16595891

Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia.

Ki-Yeon Yoo1, In Koo Hwang, Beong Ou Lim, Tae-Cheon Kang, Dong-Woo Kim, Sang Moo Kim, Hyeon Yong Lee, Jong Dai Kim, Moo Ho Won.   

Abstract

In the present study, we studied the neuroprotective effects of berberry extract (BE) against ischemic damage and the temporal and spatial alterations of N-methyl-D-aspartate receptor type 1 (NR1) and NR2A/2B immunoreactivities in the gerbil hippocampal CA1 region after transient ischemia to examine anti-ischemic effects and its role in transient forebrain ischemia. In the vehicle-treated group, the percentage of cresyl violet positive pyramidal cells in the CA1 region was about 11.4% compared to the sham-operated group 4 d after ischemic insult. BE showed neuroprotective effects against ischemic damage after ischemia-reperfusion. In the BE-treated groups, about 60-75% of CA1 pyramidal cells were stained with cresyl violet 4 d after ischemic insult. We observed the percentage of berberine (7.45+0.85 mg/g in BE) by HPLC, which is active ingredient of BE. NR1 immunoreactivity in the stratum pyramidale of the CA1 region in the vehicle-treated group was significantly increased at 30 min after transient forebrain ischemia, while at this time the NR1 immunoreactivity in the BE-treated groups was significantly low compared to the vehicle-treated group. The pattern of NR2A/B immunoreactivity in the stratum pyramidale of the BE-treated group and its protein levels were similar to that in the vehicle-treated group after ischemic insult. These results suggest that BE has potent neuroprotective effects against ischemic damage via the reduction of NR1 activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595891     DOI: 10.1248/bpb.29.623

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  18 in total

1.  Berberine Ameliorates MCAO Induced Cerebral Ischemia/Reperfusion Injury via Activation of the BDNF-TrkB-PI3K/Akt Signaling Pathway.

Authors:  Jun Yang; Hui Yan; Sumei Li; Min Zhang
Journal:  Neurochem Res       Date:  2018-01-22       Impact factor: 3.996

2.  Improving sciatic nerve regeneration by using alginate/chitosan hydrogel containing berberine.

Authors:  Majid Rahmati; Arian Ehterami; Reza Saberani; Ghasem Abbaszadeh-Goudarzi; Nariman Rezaei Kolarijani; Hossein Khastar; Behzad Garmabi; Majid Salehi
Journal:  Drug Deliv Transl Res       Date:  2020-10-09       Impact factor: 4.617

Review 3.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

4.  Berberine chloride improved synaptic plasticity in STZ induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Fatemeh Goshadrou; Abdolaziz Ronaghi
Journal:  Metab Brain Dis       Date:  2013-05-03       Impact factor: 3.584

5.  Effect of Berberine on Cell Survival in the Developing Rat Brain Damaged by MK-801.

Authors:  Taehwan Lee; Hwon Heo; Yunhee Kim Kwon
Journal:  Exp Neurobiol       Date:  2010-12-31       Impact factor: 3.261

6.  In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects.

Authors:  Abeer E Abd El-Wahab; Doaa A Ghareeb; Eman E M Sarhan; Marwa M Abu-Serie; Maha A El Demellawy
Journal:  BMC Complement Altern Med       Date:  2013-09-05       Impact factor: 3.659

7.  Inhibitory Effect of Berberis vulgaris Aqueous Extract on Acquisition and Reinstatement Effects of Morphine in Conditioned Place Preferences (CPP) in Mice.

Authors:  Mohsen Imenshahidi; Reza Qaredashi; Mahmoud Hashemzaei; Hossein Hosseinzadeh
Journal:  Jundishapur J Nat Pharm Prod       Date:  2014-06-16

8.  Neurourology transforms the drug development experience.

Authors:  Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2014-09       Impact factor: 2.835

9.  Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex.

Authors:  Tzu-Yu Lin; Yu-Wan Lin; Cheng-Wei Lu; Shu-Kuei Huang; Su-Jane Wang
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Protective effect of oxysophoridine on cerebral ischemia/reperfusion injury in mice.

Authors:  Hongbo Wang; Yuxiang Li; Ning Jiang; Xiaoping Chen; Yi Zhang; Kuai Zhang; Tengfei Wang; Yinju Hao; Lin Ma; Chengjun Zhao; Yanrong Wang; Tao Sun; Jianqiang Yu
Journal:  Neural Regen Res       Date:  2013-05-25       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.